Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001859810-25-000002
Filing Date
2025-01-29
Accepted
2025-01-29 17:20:58
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 7930
  Complete submission text file 0001859810-25-000002.txt   9707
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Issuer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Milligan Sandra (Reporting) CIK: 0001859810 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-34810 | Film No.: 25570366